Table-V.
Contrastive analysis of levels in T-lymphocyte subsets before and after treatment between two groups (χ̅±S) n=60.
| Index | Study group | Control group | t | p | |
|---|---|---|---|---|---|
| CD3+ (%) | Pre-treatment | 44.73±8.75 | 44.32±8.25 | 0.26 | 0.79 |
| Post-treatment* | 50.31±8.53 | 46.24±8.07 | 2.67 | 0.01 | |
| CD4+ (%) | Pre-treatment | 25.40±4.51 | 25.53±4.82 | 0.15 | 0.88 |
| Post-treatment* | 38.11±7.39 | 34.27±7.84 | 2.62 | 0.01 | |
| CD8+ (%) | Pre-treatment | 21.85±4.13 | 21.75±4.31 | 0.13 | 0.89 |
| Post-treatment | 22.62±5.14 | 22.57±5.07 | 0.05 | 0.96 | |
| CD4+/CD8+ | Pre-treatment | 1.38±0.41 | 1.35±0.52 | 0.35 | 0.73 |
| Post-treatment* | 1.96±0.51 | 1.46±0.27 | 6.71 | 0.00 |
p < 0.05.